In December 2014, BMC and Tufts confirmed they were engaged in merger talks. Although the two organizations haven’t finalized a deal, they have agreed to continue merger talks, and executives from both organizations have signed agreements to work out the details of the transaction.
Kate Walsh, CEO of BMC, wrote a note to the organization’s employees stating a merger deal with Tufts would allow the two organizations to join to “create a growing, thriving new organization,” according to the report.
If BMC and Tufts do reach a deal, their agreement would have to be submitted to the Massachusetts Health Policy Commission — an independent state agency responsible for reducing healthcare cost growth while improving care quality.
This week, Massachusetts Attorney General Maura Healy and House Majority Leader Ron Mariano (D-Quincy) unveiled legislation that would give the state’s Health Policy Commission more merger oversight power.
More articles on healthcare industry transactions:
Meridian Health, Raritan Bay finalize merger
10 recent hospital partnerships and transactions
Shares of Ventas spike after announcing $1.75B Ardent deal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
